Peter Fecci

"Fostering collaborations with local healthcare providers and providing info through trusted and respected channels...can help bridge the gap in healthcare disparities and improve outcomes in underserved regions," expresses CRI Lloyd J. Old STAR Dr. Iliev: bit.ly/3DeNDMM

Metastatic cancer treatments advance, offer new hope to patients - ABC11 Raleigh-Durham abc11.com/post/metastati…

Rep. Foushee Introduces Resolution Designating June as Brain and Spine Metastasis Awareness Month - Valerie Foushee. This as a result of the hard work of our outstanding DCBSM team! foushee.house.gov/posts/rep-fous…

Congratulations to my latest graduate student to graduate: Alexandra Hoyt Miggelbrink, MD, PhD

NCI SPORE meeting at the beautiful new TMC3 facility at MD Anderson

Monteris Medical Announces Extended Aetna® Coverage of its NeuroBlate® System Laser Interstitial Thermal Therapy for Brain Tumor Patients - Monteris monteris.com/press-releases…

Intracranial tumors elicit systemic sympathetic hyperactivity that limits immunotherapeutic responses biorxiv.org/cgi/content/sh… #bioRxiv

Ep. 64: "Brain Tumor Immunotherapy" Featuring Dr. Peter Fecci - The Immunology Podcast immunologypodcast.com/ep-64-brain-tu…

📣 Next week's episode features Dr. @PeterFecci from @DukeNeurosurg! His research focuses on brain tumor immunology and #immunotherapy. 🧠 Check out his lab's recent @NatureCancer paper on targeting MHC-I-negative tumor cells: bit.ly/3ZKTfWk

⭐️NEW ARTICLE @NatureCancer “CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis” by @EmilyCLerner @PeterFecci & Co. Don’t miss it👇 nature.com/articles/s4301… rdcu.be/diyEb

A Duke study published today in @NatureCancer disrupts a long-held paradigm for tumor resistance to #Immunotherapy. @EmilyCLerner @PeterFecci @prtbtcatduke @DukeCancer @DukeMedSchool @dukeresearch @dukemedicine neurosurgery.duke.edu/news/new-study…

Life changing, dogma-smashing, textbook-changing, and awesome paper by @EmilyCLerner and @PeterFecci and the rest of the wonderful Fecci lab @SelenaLorrey @DSWilkinsonPhD and others who contributed to this amazing story nature.com/articles/s4301…

Poster from @DukeMedSchool student, member of @PeterFecci's lab and all-round superstar @AdenMendoza_ : "Association of Patient Race/Ethnicity with LITT Referral Patterns at a Single Center." #AANS2023 @FLNSUS

Excellent talks by @PeterFecci, @strahleMD, and many others at the #AANS2023 Guide to Successful Research session yesterday. Such valuable information that isn’t always covered for medical students. Some key takeaways:

Outcomes in Patients with Intact and Resected #BrainMetastasis Treated with 5-Fraction Stereotactic Radiosurgery @PeterFecci @JohnHSampson @ScottFl58722881 ncbi.nlm.nih.gov/pmc/articles/P…

@DukeMets @PeterFecci

Looking forward to Friday morning wisdom for young neurosurgeons from @PeterFecci at #AANS2023

Saturday at #AANS2023, hear from our director, @PeterFecci on #BrainMetastases. @Dukeneurosurg

Amazing session discussing pearls for being a productive Neurosurgeon-Scientist Grateful for the expertise from the panel including @PeterFecci @isaacyangmd @JohnHShinMD @strahleMD @JamesRutka @DanielSciubba @Ricardokomotar @stonemcguire @nitinagarwalmd @AElsamadicyMD #AANS2023

#Wasserman Wednesday . Phenomenal @uclaneurosurgery Grand Rounds with Dr. Peter Fecci from @dukeneurosurgery and Dr. Michael Ivan from @umbti @umiamimedicine, @ucsfneurosurgery #alumni! . . #UCLAHealth #neurosurgery